TY  - JOUR
AU  - González-Rodríguez, Beatriz
AU  - Villar Gómez de las Heras, Karina
AU  - Aguirre, Daniel T.
AU  - Rodríguez-Padial, Luis
AU  - Albiñana, Virginia
AU  - Recio-Poveda, Lucía
AU  - Cuesta Martínez, Ángel
AU  - Botella, Luisa Mª
AU  - Jiménez-Escribano, Rosa María
PY  - 2019
DO  - 10.1136/bmjophth-2018-000203
SN  - 2397-3269
UR  - https://hdl.handle.net/20.500.14352/114649
T2  - BMJ Open Ophthalmology
AB  - Backgroundvon Hippel-Lindau disease (VHL) is a multisystem cancer syndrome caused by mutations in theVHLgene. Retinal hemangioblastoma is one of the most common tumours, and when it appears near the optic nerve, its treatment is challenging and risky....
LA  - eng
PB  - BMJ
TI  - Evaluation of the safety and effectiveness of oral propranolol in patients with von Hippel-Lindau disease and retinal hemangioblastomas: phase III clinical trial
TY  - journal article
VL  - 4
ER  -